JP2002508352A5 - 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体) - Google Patents
4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体) Download PDFInfo
- Publication number
- JP2002508352A5 JP2002508352A5 JP2000538984A JP2000538984A JP2002508352A5 JP 2002508352 A5 JP2002508352 A5 JP 2002508352A5 JP 2000538984 A JP2000538984 A JP 2000538984A JP 2000538984 A JP2000538984 A JP 2000538984A JP 2002508352 A5 JP2002508352 A5 JP 2002508352A5
- Authority
- JP
- Japan
- Prior art keywords
- pyran
- aminomethyl
- thio
- substituted
- piperidine derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical class OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title 2
- 229960002870 gabapentin Drugs 0.000 title 1
- 150000003053 piperidines Chemical class 0.000 title 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
Description
【特許請求の範囲】
【請求項1】 下記式:
【化29】
[式中、nは0〜2の整数であり;
Rは下記:
【化30】
から選択される複素環であり;
Xは−O−、−S−、−S(O)−、−S(O)2−またはNR′1であり、ここでR′1は水素、炭素原子1〜6個の直鎖または分枝鎖のアルキル、ベンジル、−C(O)R′2(た
だしR′2は炭素原子1〜6個の直鎖または分枝鎖のアルキル、ベンジルまたはフェニルである)、または、−C(O)2R′3(ただしR′3は炭素原子1〜6個の直鎖または分枝鎖のアルキルまたはベンジルである)であり、ここでベンジルまたはフェニル基は未置換であるか、ハロゲン、トリフルオロメチルおよびニトロから選択される置換基1〜3個で置換されることができる]の化合物または製薬上許容しうるその塩。
【請求項1】 下記式:
【化29】
[式中、nは0〜2の整数であり;
Rは下記:
【化30】
から選択される複素環であり;
Xは−O−、−S−、−S(O)−、−S(O)2−またはNR′1であり、ここでR′1は水素、炭素原子1〜6個の直鎖または分枝鎖のアルキル、ベンジル、−C(O)R′2(た
だしR′2は炭素原子1〜6個の直鎖または分枝鎖のアルキル、ベンジルまたはフェニルである)、または、−C(O)2R′3(ただしR′3は炭素原子1〜6個の直鎖または分枝鎖のアルキルまたはベンジルである)であり、ここでベンジルまたはフェニル基は未置換であるか、ハロゲン、トリフルオロメチルおよびニトロから選択される置換基1〜3個で置換されることができる]の化合物または製薬上許容しうるその塩。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6977397P | 1997-12-16 | 1997-12-16 | |
US60/069,773 | 1997-12-16 | ||
US10490498P | 1998-10-20 | 1998-10-20 | |
US60/104,904 | 1998-10-20 | ||
PCT/US1998/023991 WO1999031057A1 (en) | 1997-12-16 | 1998-11-10 | 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002508352A JP2002508352A (ja) | 2002-03-19 |
JP2002508352A5 true JP2002508352A5 (ja) | 2006-01-05 |
Family
ID=26750407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000538984A Abandoned JP2002508352A (ja) | 1997-12-16 | 1998-11-10 | 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体)、それらの製法および神経病理学的疾患の治療における使用 |
Country Status (16)
Country | Link |
---|---|
US (1) | US6545022B1 (ja) |
EP (1) | EP1045834A1 (ja) |
JP (1) | JP2002508352A (ja) |
KR (1) | KR20010033153A (ja) |
CN (1) | CN1279667A (ja) |
AU (1) | AU759392B2 (ja) |
BR (1) | BR9814287A (ja) |
CA (1) | CA2304967C (ja) |
HU (1) | HUP0100069A3 (ja) |
IL (1) | IL135315A0 (ja) |
IS (1) | IS5434A (ja) |
NO (1) | NO20003038D0 (ja) |
NZ (1) | NZ503980A (ja) |
PL (1) | PL341231A1 (ja) |
TR (1) | TR200001800T2 (ja) |
WO (1) | WO1999031057A1 (ja) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6284794B1 (en) * | 1996-11-05 | 2001-09-04 | Head Explorer Aps | Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase |
AU2002211863A1 (en) | 2000-10-06 | 2002-04-15 | Xenoport, Inc. | Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration |
WO2002032376A2 (en) | 2000-10-06 | 2002-04-25 | Xenoport, Inc. | Bile-acid conjugates for providing sustained systemic concentrations of drugs |
US6620829B2 (en) | 2000-10-17 | 2003-09-16 | Warner-Lambert Company | Method of treating noninflammatory cartilage damage |
GB2368579A (en) * | 2000-10-31 | 2002-05-08 | Parke Davis & Co Ltd | Azole pharmaceutical agents |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
AU2002310409C1 (en) | 2001-06-11 | 2008-04-17 | Xenoport, Inc. | Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
EP1412324A4 (en) | 2001-06-11 | 2004-09-29 | Xenoport Inc | AMINO ACID CONJUGATES THAT RESULT IN GABA ANALOGA LASTING SYSTEMIC CONCENTRATIONS |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
IL162028A0 (en) * | 2002-01-31 | 2005-11-20 | Warner Lambert Co | Alpha 2 delta ligands to treat tinnitus |
US6927036B2 (en) | 2002-02-19 | 2005-08-09 | Xero Port, Inc. | Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
RU2286151C2 (ru) * | 2002-02-22 | 2006-10-27 | Уорнер-Ламберт Компани Ллс | Комбинации альфа-2-дельта-лиганда с селективным ингибитором циклооксигеназы-2 |
AU2003222033A1 (en) | 2002-03-20 | 2003-10-08 | Xenoport | Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof |
AU2003243180A1 (en) | 2002-05-17 | 2003-12-12 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
BR0312240A (pt) * | 2002-06-27 | 2005-04-12 | Warner Lambert Co | Método de tratamento do distúrbio por déficit de atenção com hiperatividade |
WO2004052360A1 (en) | 2002-12-11 | 2004-06-24 | Xenoport, Inc. | Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof |
ES2341240T3 (es) | 2002-12-13 | 2010-06-17 | Warner-Lambert Company Llc | Ligando alfa-2-delta para tratar los sintomas del tracto urinario inferior. |
CA2451267A1 (en) | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
MXPA05009504A (es) | 2003-03-07 | 2005-10-18 | Warner Lambert Co | Derivados de (-aminoacidos sustituidos con tetrazol y oxadiazolona. |
WO2005013888A2 (en) * | 2003-05-14 | 2005-02-17 | Cytokinetics, Inc. | Compounds, compositions and methods |
US20040248979A1 (en) * | 2003-06-03 | 2004-12-09 | Dynogen Pharmaceuticals, Inc. | Method of treating lower urinary tract disorders |
EP1670451A4 (en) | 2003-09-11 | 2009-10-21 | Xenoport Inc | TREATMENT AND / OR PREVENTION OF URINARY INCONTINENCE AND PROMOTERS OF GABA ANALOGS |
RU2320369C2 (ru) | 2003-09-12 | 2008-03-27 | Пфайзер Инк. | Комбинации, содержащие альфа-2-дельта лиганды и ингибиторы обратного захвата серотонина/норадреналина |
RU2377234C2 (ru) * | 2003-09-17 | 2009-12-27 | Ксенопорт, Инк. | Лечение или предупреждение синдрома беспокойных ног с использованием пролекарств аналогов гамк |
US8114909B2 (en) | 2003-09-17 | 2012-02-14 | Xenoport, Inc. | Treating or preventing restless legs syndrome using prodrugs of GABA analogs |
NZ546381A (en) | 2003-10-14 | 2010-01-29 | Xenoport Inc | Crystalline form of gamma-aminobutyric acid analog |
PL1691811T3 (pl) | 2003-12-11 | 2014-12-31 | Sunovion Pharmaceuticals Inc | Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji |
CA2556589A1 (en) * | 2004-02-24 | 2005-09-01 | Bioaxone Therapeutique Inc. | 4-substituted piperidine derivatives |
US20050209319A1 (en) * | 2004-03-18 | 2005-09-22 | Xenoport, Inc. | Treatment of local pain |
US20060025477A1 (en) * | 2004-07-22 | 2006-02-02 | Artman Linda D | Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases |
JP4880473B2 (ja) * | 2004-10-08 | 2012-02-22 | 壽製薬株式会社 | ホスホン酸誘導体及び血中の高リン酸が関与する疾患の治療剤 |
EP1811986B1 (en) | 2004-11-04 | 2014-03-26 | XenoPort, Inc. | Gabapentin prodrug sustained release oral dosage forms |
EP1820502A1 (en) | 2006-02-10 | 2007-08-22 | Laboratorios Del Dr. Esteve, S.A. | Active substance combination comprising azolylcarbinol compounds |
MX2009006575A (es) | 2006-12-22 | 2009-07-02 | Recordati Ireland Ltd | Terapia de combinacion de trastornos del tracto urinario inferior con ligandos a2d y farmacos anti-inflamatorios no esteroidales (nsaids). |
US20080306116A1 (en) * | 2007-06-08 | 2008-12-11 | Christ Andreas D | Aryloxazole, aryloxadiazole and benzimidazole derivatives |
EP2190833A1 (en) * | 2007-08-23 | 2010-06-02 | Novartis Ag | Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors |
CA2706575C (en) | 2008-01-25 | 2015-07-14 | Xenoport, Inc. | Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs |
US7872046B2 (en) | 2008-01-25 | 2011-01-18 | Xenoport, Inc. | Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use |
WO2009094577A2 (en) | 2008-01-25 | 2009-07-30 | Xenoport, Inc. | Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use |
EP2116539A1 (en) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof |
CN105330603A (zh) | 2008-10-08 | 2016-02-17 | 凯飞药业公司 | Gaba偶联物及其使用方法 |
EP2353598A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for use in the prevention and/or treatment of postoperative pain |
EP2353591A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
EP2388005A1 (en) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
EP2415471A1 (en) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in opioid-induced hyperalgesia |
EP2524694A1 (en) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in diabetes type-2 associated pain |
US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
US9066853B2 (en) | 2013-01-15 | 2015-06-30 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable fiber |
AU2014209028C1 (en) | 2013-01-28 | 2019-08-29 | Hector L. Lopez | Methods of improving tolerability, pharmacodynamics, and efficacy of b-alanine and use therefor |
MA39146A1 (fr) | 2013-12-17 | 2017-11-30 | Esteve Labor Dr | Combinaisons de gabapentanoïdes et de ligands des récepteurs sigma |
AU2014364647A1 (en) | 2013-12-17 | 2016-06-23 | Laboratorios Del Dr. Esteve, S.A. | Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) and Sigma receptor ligands combinations |
US10149856B2 (en) | 2015-01-26 | 2018-12-11 | BioAxone BioSciences, Inc. | Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors |
US10857157B2 (en) | 2015-01-26 | 2020-12-08 | BioAxone BioSciences, Inc. | Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors |
US10106525B2 (en) | 2015-01-26 | 2018-10-23 | BioAxone BioSciences, Inc. | Rho kinase inhibitor BA-1049 (R) and active metabolites thereof |
US11198680B2 (en) | 2016-12-21 | 2021-12-14 | BioAxone BioSciences, Inc. | Rho kinase inhibitor BA-1049 (R) and active metabolites thereof |
US10537567B2 (en) | 2017-07-11 | 2020-01-21 | BioAxone BioSciences, Inc. | Kinase inhibitors for treatment of disease |
CA3099775A1 (en) | 2018-05-14 | 2019-11-21 | Xgene Pharmaceutical Inc. | Process for making 1-(acyloxy)-alkyl-carabmate drug conjugates of naproxen and pregabalin |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4087544A (en) | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
DE2460891C2 (de) | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
US6197819B1 (en) | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
FR2674522B1 (fr) * | 1991-03-26 | 1993-07-16 | Lipha | Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant. |
PT888325E (pt) * | 1996-02-07 | 2002-10-31 | Warner Lambert Co | Novos amino acidos ciclicos como agentes farmaceuiticos |
AU765802B2 (en) * | 1997-12-16 | 2003-10-02 | Warner-Lambert Company | 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
-
1998
- 1998-11-10 US US09/529,055 patent/US6545022B1/en not_active Expired - Fee Related
- 1998-11-10 WO PCT/US1998/023991 patent/WO1999031057A1/en not_active Application Discontinuation
- 1998-11-10 EP EP98958528A patent/EP1045834A1/en not_active Ceased
- 1998-11-10 JP JP2000538984A patent/JP2002508352A/ja not_active Abandoned
- 1998-11-10 NZ NZ503980A patent/NZ503980A/xx unknown
- 1998-11-10 HU HU0100069A patent/HUP0100069A3/hu unknown
- 1998-11-10 CA CA002304967A patent/CA2304967C/en not_active Expired - Fee Related
- 1998-11-10 KR KR1020007006529A patent/KR20010033153A/ko not_active Application Discontinuation
- 1998-11-10 BR BR9814287-9A patent/BR9814287A/pt not_active Application Discontinuation
- 1998-11-10 CN CN98811479A patent/CN1279667A/zh active Pending
- 1998-11-10 IL IL13531598A patent/IL135315A0/xx unknown
- 1998-11-10 AU AU14554/99A patent/AU759392B2/en not_active Ceased
- 1998-11-10 PL PL98341231A patent/PL341231A1/xx unknown
- 1998-11-10 TR TR2000/01800T patent/TR200001800T2/xx unknown
-
2000
- 2000-04-07 IS IS5434A patent/IS5434A/is unknown
- 2000-06-14 NO NO20003038A patent/NO20003038D0/no not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002508352A5 (ja) | 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体) | |
JP2002508362A5 (ja) | 1−置換−1−アミノメチル−シクロアルカン誘導体(=ガバペンチン類縁体) | |
JP2003531118A5 (ja) | ||
JP2002543183A5 (ja) | ||
RU2002107975A (ru) | Глюкопиранозилоксипиразольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для их получения | |
JP2002541233A5 (ja) | ||
EP1797878A3 (en) | Benzothiazole derivatives | |
JP2003528852A5 (ja) | ||
JP2003519676A5 (ja) | ||
JP2002060340A5 (ja) | ||
JP2001519410A5 (ja) | ||
JP2001526218A5 (ja) | ||
JP2003523927A5 (ja) | ||
EP0850926A3 (en) | Difluoroprostaglandin derivatives and their use | |
JP2002332234A5 (ja) | ||
JP2002508361A5 (ja) | ||
JP2002518502A5 (ja) | ||
JP2004501940A5 (ja) | ||
JP2002525323A5 (ja) | ||
JP2003503449A5 (ja) | ||
JP2002525330A5 (ja) | ||
JP2002535387A5 (ja) | ||
JP2002520286A5 (ja) | ||
JP2002506864A5 (ja) | ||
JP2004502732A5 (ja) |